Only 6% of health system execs have a gen AI strategy

Although 75 percent of health system executives believe generative AI has reached a turning point in the healthcare industry, only 6 percent reported having a generative AI strategy for their organization, an Aug. 7 survey from Bain & Company found. 

Advertisement

The survey found that health executives are deeply concerned about rising costs, as many organizations ended 2022 with negative margins, but that few are leveraging generative AI to help improve their productivity and cost efficiencies. 

In the survey, health system executives said they are laser-focused on reducing administrative burdens and enhancing operational efficiency. 

Clinical documentation, structuring and analyzing patient data, and optimizing workflows were listed as their top three priorities for the next 12 months, according to the survey. 

But executives haven’t deployed a generative AI strategy as there is still a lot of gray area with the technology. 

According to those surveyed, “resource and cost constraints, a lack of expertise, and regulatory and legal considerations are the largest barriers to implementing generative AI.”

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.